Expression and Function of the Alpha 7 Nicotinic Receptor in Schizophrenia
Expression and Function of the Alpha 7 Nicotinic Receptor in Schizophrenia
批准号:
8137492
负责人:
SHERRY LEONARD
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2014-12-31
关键词:
AffectAgonistAmino Acid SequenceAutopsyBindingBinding SitesBrainBungarotoxinsCandidate Disease GeneCell LineChimera organismChromosomes, Human, Pair 3Cigarette SmokerCognitionCognitive deficitsComplexCoupledDataDeletion MutationDevelopmentDivalent CationsDominant-Negative MutationDrug Delivery SystemsExonsGene ExpressionGene StructureGeneral PopulationGenesGenetic TranscriptionGenotypeHippocampus (Brain)HumanInflammationLengthLigand BindingMammalian CellMeasuresMessenger RNAModelingMolecularMono-SNeuronsNicotineNicotine DependenceNicotinic ReceptorsNucleic Acid Regulatory SequencesOocytesPatientsPeptide Sequence DeterminationPeptidesPlayPrevalenceProcessProtein SubunitsProteinsReceptor GeneRegulationResearchRoleSchizophreniaSelf MedicationSmokeSmokerSmokingStreamStressStructureSurfaceSynapsesSystemTranscription Initiation SiteTranslatingTranslationsVeteransaddictionalpha Bungarotoxinchimeric genedensitydrug developmentduplicate geneshuman tissuein vivomRNA Expressionmutantneurotransmitter releasenon-smokerpromoterprotein expressionreceptorresearch studytissue culture
中文摘要
描述(由申请人提供):
17神经元烟碱型乙酰胆碱受体基因(CHRNA7)是精神分裂症的复制候选基因,对炎症和应激也有保护作用。来自该基因的蛋白质亚基(17)与其他四个类似的亚基组装形成五聚体的功能性17*受体,该受体有五个激动剂结合部位。17*受体是治疗精神分裂症认知障碍药物开发的重要靶点。激动剂刺激导致通道开放和包括钙离子在内的单价和二价阳离子进入,导致突触前神经递质释放,突触后调节突触后密度(PSD),并导致基因表达的下游变化。CHRNA7的结构复杂,部分复制为嵌合基因(CHRFAM7A)。表达了嵌合体CHRFAM7A。最近的数据表明,CHRFAM7A是CHRNA7结合和功能的主要负调控因子。CHRFAM7A基因2bp缺失与精神分裂症有关,并导致CHRNA7功能进一步下降。精神分裂症患者的17*受体水平较低,通过与配体[125I]-1-银环蛇毒素(I-BTX)的结合来衡量。这些患者大多是重度吸烟者。与对照组相比,精神分裂症非吸烟者的信使核糖核酸和蛋白质表达减少,但在大多数吸烟者中,信使核糖核酸和蛋白质的表达水平正常。因此,精神分裂症患者的I-BTX结合水平低并不能用CHRNA7的mRNA或蛋白表达来解释。我们推测,复制的CHRFAM7A基因作为一个显性负调控因子,降低了17*受体的表面结合和功能。目前的建议将表征CHRFAM7A基因的结构、表达和调控,并研究其与全长基因CHRNA7的相互作用。
公共卫生相关性:
退伍军人中精神分裂症的患病率约为10%,远远高于普通人群。退伍军人对尼古丁的上瘾程度更高,约为35%,而普通人群的上瘾比例为22%。吸烟与精神分裂症密切相关,因为80%以上的精神分裂症患者吸烟,可能是一种自我药物治疗。尼古丁受体与精神分裂症和吸烟有关。17*烟碱乙酰胆碱受体是精神分裂症的复制候选基因,它在精神分裂症患者脑中的表达降低,并在尼古丁成瘾中发挥作用。受体基因CHRNA7的部分复制调节其功能。这项建议将在分子水平上表征CHRFAM7A的部分复制,并研究其在精神分裂症中的表达。这项拟议的研究将有助于开发另外17种受体靶向的认知药物。
英文摘要
DESCRIPTION (provided by applicant):
The 17 neuronal nicotinic acetylcholine receptor gene (CHRNA7) is a replicated candidate gene for schizophrenia and is also protective in inflammation and stress. The protein subunit (17), derived from the gene, assembles with four other like subunits to form the pentameric, functional 17* receptor, which has five agonist-binding sites. The 17* receptor is an important target in drug development for cognitive deficits in schizophrenia. Agonist stimulation results in opening of the channel and entry of mono- and divalent cations, including Ca++, leading presynaptically to neurotransmitter release and postsynaptically to regulation at the post-synaptic density (PSD) and to down-stream changes in gene expression. Structure of CHRNA7, is complex; it is partially duplicated as a chimeric gene (CHRFAM7A). The chimera, CHRFAM7A, is expressed. Recent data suggests that CHRFAM7A acts as a dominant negative regulator of CHRNA7 binding and function. A 2bp deletion in CHRFAM7A is associated with schizophrenia and results in further decreasing CHRNA7 function. Schizophrenic patients have low levels of 17* receptors, as measured by binding of the ligand [125I]-1-bungarotoxin (I-BTX). Most of these patients are heavy cigarette smokers. The mRNA and protein in schizophrenic non-smokers is reduced compared to controls, but in the majority of subjects who smoke, there are normal levels of mRNA and protein. Thus, the low levels of I-BTX binding in schizophrenic patients are not explained by CHRNA7 mRNA or protein expression. We hypothesize that the duplicated gene, CHRFAM7A, acting as a dominant negative regulator, decreases the surface binding and function of 17* receptors. The current proposal will characterize the structure, expression and regulation of the CHRFAM7A gene and investigate its interaction with the full-length gene, CHRNA7.
PUBLIC HEALTH RELEVANCE:
The prevalence of schizophrenia is approximately 10% in Veterans, much higher than in the general population. Addiction, particularly to nicotine, is higher, ~35% in Veterans compared to 22% in the general population. Smoking and schizophrenia are intimately related since more than 80% of schizophrenics smoke, possibly as a form of self-medication. Nicotinic receptors are involved in both schizophrenia and smoking. The 17* nicotinic acetylcholine receptor, a replicated candidate gene in schizophrenia, is decreased in expression in schizophrenic brain and plays a role in nicotine addiction. A partial duplication of the receptor gene, CHRNA7, regulates its function. This proposal will characterize the partial duplication, CHRFAM7A, at the molecular level and study its expression in schizophrenia. The proposed research will contribute to development of additional 17* receptor-targeted drugs for cognition.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Expression and Function of the Alpha 7 Nicotinic Receptor in Schizophrenia
-
批准号:8255311
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:SHERRY LEONARD
-
依托单位:
Expression and Function of the Alpha 7 Nicotinic Receptor in Schizophrenia
-
批准号:8398953
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of the Human a7 Nicotinic Receptor Gene in Schizophrenia
-
批准号:7871065
-
项目类别:
-
资助金额:$30.12万
-
财政年份:2009
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of the Human a7 Nicotinic Receptor Gene in Schizophrenia
-
批准号:8063988
-
项目类别:
-
资助金额:$27.44万
-
财政年份:2007
-
负责人:SHERRY LEONARD
-
依托单位:
MOLECULAR BIOLOGY OF NICOTINIC RECEPTORS
-
批准号:7449573
-
项目类别:
-
资助金额:$41.08万
-
财政年份:2007
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of the Human a7 Nicotinic Receptor Gene in Schizophrenia
-
批准号:7807156
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2007
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of the Human a7 Nicotinic Receptor Gene in Schizophrenia
-
批准号:7301548
-
项目类别:
-
资助金额:$27.23万
-
财政年份:2007
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of the Human a7 Nicotinic Receptor Gene in Schizophrenia
-
批准号:7612655
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2007
-
负责人:SHERRY LEONARD
-
依托单位:
MOLECULAR BIOLOGY OF NICOTINIC RECEPTORS
-
批准号:6969112
-
项目类别:
-
资助金额:$48.9万
-
财政年份:2004
-
负责人:SHERRY LEONARD
-
依托单位:
NICOTINIC RECEPTORS AND SMOKING CESSATION
-
批准号:6174839
-
项目类别:
-
资助金额:$12.9万
-
财政年份:1998
-
负责人:SHERRY LEONARD
-
依托单位:
NICOTINIC RECEPTORS AND SMOKING CESSATION
-
批准号:2898307
-
项目类别:
-
资助金额:$12.53万
-
财政年份:1998
-
负责人:SHERRY LEONARD
-
依托单位:
NICOTINIC RECEPTORS AND SMOKING CESSATION
-
批准号:2763946
-
项目类别:
-
资助金额:$12.16万
-
财政年份:1998
-
负责人:SHERRY LEONARD
-
依托单位:
GENETIC DETERMINANTS OF RECEPTOR FUNCTION IN SCHIZOPHRENIA
-
批准号:6111439
-
项目类别:
-
资助金额:$0.0万
-
财政年份:1998
-
负责人:SHERRY LEONARD
-
依托单位:
GENETIC DETERMINANTS OF RECEPTOR FUNCTION IN SCHIZOPHRENIA
-
批准号:6243057
-
项目类别:
-
资助金额:$21.21万
-
财政年份:1997
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of Alpha 7 Nicotinic Receptor Assembly in Human Smokers
-
批准号:8013847
-
项目类别:
-
资助金额:$28.99万
-
财政年份:1995
-
负责人:SHERRY LEONARD
-
依托单位:
Regulation of Alpha 7 Nicotinic Receptor Assembly in Human Smokers
-
批准号:7755428
-
项目类别:
-
资助金额:$29.88万
-
财政年份:1995
-
负责人:SHERRY LEONARD
-
依托单位:
HUMAN BRAIN NICOTINIC RECEPTORS AND NICOTINE ADDICTION
-
批准号:2122705
-
项目类别:
-
资助金额:$20.0万
-
财政年份:1995
-
负责人:SHERRY LEONARD
-
依托单位:
HUMAN BRAIN NICOTINIC RECEPTORS AND NICOTINE ADDICTION
-
批准号:6126638
-
项目类别:
-
资助金额:$26.39万
-
财政年份:1995
-
负责人:SHERRY LEONARD
-
依托单位:
HUMAN BRAIN NICOTINIC RECEPTORS AND NICOTINE ADDICTION
-
批准号:2122706
-
项目类别:
-
资助金额:$20.73万
-
财政年份:1995
-
负责人:SHERRY LEONARD
-
依托单位:
HUMAN BRAIN NICOTINIC RECEPTORS AND NICOTINE ADDICTION
-
批准号:2733552
-
项目类别:
-
资助金额:$22.42万
-
财政年份:1995
-
负责人:SHERRY LEONARD
-
依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
-
批准号:32000851
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:乔安娜
-
依托单位: